Rallybio Corporation ("Rallybio") and Candid Therapeutics, Inc. ("Candid"), a global clinical-stage biotechnology company advancing a leading portfolio of T-cell engager ("TCE") therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results